Page last updated: 2024-08-23

amikacin and Koch's Disease

amikacin has been researched along with Koch's Disease in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (13.73)	18.7374
1990's	12 (23.53)	18.2507
2000's	12 (23.53)	29.6817
2010's	13 (25.49)	24.3611
2020's	7 (13.73)	2.80

Authors

Authors	Studies
Chhabria, MT; Jani, MH	1
Camoin, L; Canaan, S; Cavalier, JF; Durand, T; Spilling, CD	1
Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L	1
Daneshfar, S; Hashemzadeh, M; Khosravi, AD	1
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A	1
Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F	1
Anton, C; Bernardi, RM; Freitas, AA; Lemos, CX; Machado, FD; Silva, DR	1
Dominic, C; Gill, LI; Tiberi, S	1
Bam, L; Coetzee, E; McLaren, ZM; von Leipzig, KH	1
Akkerman, OW; Alffenaar, JC; Bolhuis, MS; Huisman, JR; Touw, DJ; van den Elsen, SHJ; van der Werf, TS	1
Dai, G; Huang, H; Jiang, G; Jin, Q; Liu, L; Peng, J; Zhang, X; Zhao, B; Zhao, Y; Zhu, Y	1
Aubry, A; Brossier, F; Chauffour, A; Fillion, A; Jarlier, V; Veziris, N	1
Dai, G; Dong, L; Du, Q; Huang, H; Long, Q; Xie, J; Yu, X	1
Chen, X; Huang, H; Jiang, GL; Kam, KM; Song, Y; Zhao, Y	1
Alkhovik, OI; Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Petrenko, TI	1
Alland, D; Barry, CE; Chakravorty, S; Cho, EJ; Cho, SN; Kim, CT; Lee, J; Lee, JS; Roh, SS; Smith, LE; Via, LE	1
Bisht, D; Joshi, B; Kumar, B; Lata, M; Sharma, D; Shukla, S; Venkatesan, K	1
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X	1
Deshpande, D; Gumbo, T; Modongo, C; Pasipanodya, JG; Siyambalapitiyage Dona, CW; Srivastava, S	1
Bonato, D; Desmond, E; Gross, W; Lin, SY; Siddiqi, S	1
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A	1
Ankomah, P; Levin, BR	1
Woo, PC; Yuen, KY	1
Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA	1
Ghebremichael, S; Hoffner, S; Jureen, P; Krüüner, A; Levina, K	1
Berning, SE; Cook, JL; Curran-Everett, D; Goble, M; Huitt, GA; Iseman, MD; Nitta, AT; Peloquin, CA; Simone, PM	1
Głowacka, M; Kurek, J; Sandelewski, A; Wyrobiec, G	1
Bakker-Woudenberg, IA; de Steenwinkel, JE; Schiffelers, RM; Ten Kate, MT; van Agtmael, MA; van Vianen, W; Verbrugh, HA	1
Aichelburg, A; Aspöck, H; Assadian, O; Steuer, A; Vetter, N; Visvesvara, G; Walochnik, J	1
Fodor, T	1
Barletta, RG; Bermudez, LE; Foley-Thomas, EM; Whipple, DL	1
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ	1
Hara, K; Koga, H; Kohno, S; Miyazaki, Y	1
Bancroff, G; Bucke, W; Ehlers, S; Fortmann, L; Hahn, H; Hänsch, H; Leitzke, S; Müller, R; Smith, D	1
Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C	1
Björkholm, M; Engervall, P; Kalin, M	1
Clumeck, N; De Wit, S; Payen, MC	1
Creti, R; Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Ricci, ML; Thoresen, OF; Xiao, Y	1
Borner, K; Bucke, W; Ehlers, S; Hahn, H; Leitzke, S; Müller, R	1
Fattorini, L; Iona, E; Li, Y; Mattei, M; Orefici, G; Thoresen, OF; Xiao, Y	1
Adler-Moore, J; Dhillon, J; Fielding, R; Goodall, RL; Mitchison, D	1
de Jager, P; van Altena, R	1
Okuyama, T; Shimizu, T; Yoshida, U	1
Inoue, I; Sakurai, H; Yamagami, K; Yamamoto, K	1
Cynamon, MH; DeStefano, MS; Klemens, SP	1
Cynamon, MH; Klemens, SP; Swenson, CE	1
Gangadharam, PR; Iseman, MD; Kesavalu, L; Perumal, VK; Podapati, NR	1
de Kantor, IN	1
Debs, RJ; Düzgüneş, N; Gangadharam, PR; Goldstein, JA; Kesavalu, L; Perumal, VK	1
Baron, EJ; Young, LS	1

Reviews

7 review(s) available for amikacin and Koch's Disease

Article	Year
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Antitubercular Agents; Carboxylic Ester Hydrolases; Drug Design; Enzyme Inhibitors; Humans; Lactones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Organophosphorus Compounds; Orlistat; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Atypical mycobacterial infections - management and when to treat. Current opinion in pulmonary medicine, 2021, 05-01, Volume: 27, Issue:3 Topics: Amikacin; Animals; Antitubercular Agents; Humans; Lung Diseases; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tuberculosis	2021
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis	2010
Tuberculosis in blood and marrow transplant recipients. Hematological oncology, 2002, Volume: 20, Issue:2 Topics: Adult; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Female; Graft vs Host Disease; Humans; Incidence; Male; Mycobacterium tuberculosis; Rifampin; Risk Factors; Transfusion Reaction; Tuberculosis; Whole-Body Irradiation	2002
Amikacin. Tuberculosis (Edinburgh, Scotland), 2008, Volume: 88, Issue:2 Topics: Amikacin; Animals; Antitubercular Agents; Humans; Mice; Treatment Outcome; Tuberculosis	2008
[A drug delivery system and biological response modifiers for the treatment of mycobacterial infection]. Kekkaku : [Tuberculosis], 1994, Volume: 69, Issue:2 Topics: Amikacin; Animals; Drug Delivery Systems; Humans; Immunologic Factors; Immunotherapy, Adoptive; Liposomes; Mice; Streptomycin; Tuberculosis	1994
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. Revue des maladies respiratoires, 1997, Volume: 14 Suppl 5 Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss	1997

Trials

1 trial(s) available for amikacin and Koch's Disease

Article	Year
Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38, Issue:11 Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kanamycin; Kidney; Male; Middle Aged; Mycobacterium Infections; Streptomycin; Tuberculosis; Vestibule, Labyrinth	2004

Article

Year

Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38, Issue:11

Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kanamycin; Kidney; Male; Middle Aged; Mycobacterium Infections; Streptomycin; Tuberculosis; Vestibule, Labyrinth

2004

Other Studies

43 other study(ies) available for amikacin and Koch's Disease

Article	Year
Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines. European journal of medicinal chemistry, 2009, Volume: 44, Issue:10 Topics: Antitubercular Agents; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyrimidines; Structure-Activity Relationship; Tuberculosis	2009
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:2 Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran. PloS one, 2022, Volume: 17, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis	2022
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. BMC infectious diseases, 2023, Sep-28, Volume: 23, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2023
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 96 Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing	2020
Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality. Tropical medicine & international health : TM & IH, 2021, Volume: 26, Issue:1 Topics: Adult; Amikacin; Antibiotics, Antitubercular; APACHE; Brazil; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Intensive Care Units; Isoniazid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis	2021
Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management. Health policy and planning, 2017, Oct-01, Volume: 32, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Drugs, Essential; Humans; Resource Allocation; South Africa; Systems Analysis; Tuberculosis	2017
Lack of penetration of amikacin into saliva of tuberculosis patients. The European respiratory journal, 2018, Volume: 51, Issue:1 Topics: Adult; Amikacin; Aminoglycosides; Drug Monitoring; Female; Humans; Immunoassay; Male; Middle Aged; Prospective Studies; Saliva; Treatment Outcome; Tuberculosis	2018
Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7 Topics: Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Genotype; Humans; Molecular Typing; Mycobacterium tuberculosis; Phenotype; Tuberculosis	2013
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Amikacin; Animals; Antitubercular Agents; Aza Compounds; DNA Gyrase; Drug Administration Schedule; Drug Resistance, Bacterial; Ethionamide; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Quinolines; Recurrence; Rodent Diseases; Survival Analysis; Tuberculosis	2013
Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagnostic microbiology and infectious disease, 2013, Volume: 77, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; RNA, Ribosomal, 16S; Tuberculosis	2013
First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Bacterial; Humans; Kanamycin; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Observer Variation; Ofloxacin; Predictive Value of Tests; Quality Control; Quality Indicators, Health Care; Reproducibility of Results; Tuberculosis	2013
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. BMC infectious diseases, 2014, Sep-03, Volume: 14 Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Siberia; Tuberculosis; Young Adult	2014
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testin Journal of clinical microbiology, 2015, Volume: 53, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotyping Techniques; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets. PloS one, 2015, Volume: 10, Issue:10 Topics: Amikacin; Amino Acid Motifs; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Cell Membrane; Conserved Sequence; Drug Delivery Systems; Drug Resistance, Microbial; Electrophoresis, Gel, Two-Dimensional; Humans; Iron; Kanamycin; Kanamycin Resistance; Membrane Proteins; Models, Molecular; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Conformation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Proteomics; Sequence Alignment; Sequence Homology, Amino Acid; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Tuberculosis; Ubiquitins	2015
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:3 Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2016
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Amikacin; Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant	2016
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. Journal of clinical microbiology, 2009, Volume: 47, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis	2009
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. PLoS pathogens, 2012, Volume: 8, Issue:1 Topics: Amikacin; Anti-Infective Agents; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Models, Biological; Models, Theoretical; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Rifampin; Tuberculosis	2012
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2002, Volume: 33, Issue:3 Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis	2002
Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Estonia; Genes, Bacterial; Genotype; Kanamycin; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Tuberculosis	2003
Acute isolated tuberculous appendicitis. Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:3 Topics: Adult; Amikacin; Antibiotics, Antitubercular; Antitubercular Agents; Appendicitis; Appendix; Female; Humans; Metronidazole; Tuberculosis	2006
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5 Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Delivery Systems; Ethambutol; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Specific Pathogen-Free Organisms; Tuberculosis	2007
Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virus-negative patient. Journal of clinical microbiology, 2008, Volume: 46, Issue:1 Topics: Acanthamoeba; Adult; Amebiasis; Amikacin; Animals; Antiprotozoal Agents; Antitubercular Agents; DNA, Protozoan; Encephalitis; Genotype; HIV Infections; Humans; Male; Molecular Sequence Data; Phosphorylcholine; Sequence Analysis, DNA; Skin Diseases, Parasitic; Tuberculosis	2008
Amikacin in experimental tuberculosis of guinea pigs. Acta microbiologica Academiae Scientiarum Hungaricae, 1982, Volume: 29, Issue:2 Topics: Amikacin; Animals; Guinea Pigs; Kanamycin; Male; Tuberculosis	1982
Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology (Reading, England), 1995, Volume: 141 ( Pt 5) Topics: AIDS-Related Opportunistic Infections; Amikacin; Animals; Bacteriophages; Humans; Kanamycin; Kinetics; Luciferases; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium subsp. paratuberculosis; Plasmids; Recombinant Proteins; Species Specificity; Transfection; Transformation, Bacterial; Tuberculosis	1995
Rifampin-resistant Mycobacterium kansasii. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis	1994
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1996, Volume: 284, Issue:2-3 Topics: Amikacin; Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Granuloma; Injections, Intravenous; Liposomes; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mycobacterium avium; Time Factors; Tuberculosis	1996
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5 Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Female; Mice; Mice, Nude; Mycobacterium avium; Predictive Value of Tests; Species Specificity; Tuberculosis	1997
Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:4 Topics: Abscess; Adrenal Gland Diseases; Aged; Amikacin; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Pulmonary	1997
Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3 Topics: Amikacin; Animals; Clarithromycin; Drug Therapy, Combination; Humans; Isoniazid; Lung; Mice; Mycobacterium avium; Spleen; Tuberculosis	1998
Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:2 Topics: Amikacin; Animals; Anti-Bacterial Agents; Delayed-Action Preparations; Drug Carriers; Female; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Tuberculosis	1998
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. Microbial drug resistance (Larchmont, N.Y.), 1999,Fall, Volume: 5, Issue:3 Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Male; Mice; Mycobacterium avium; Tuberculosis	1999
The activity of low-clearance liposomal amikacin in experimental murine tuberculosis. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6 Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Liposomes; Lung; Mice; Mycobacterium tuberculosis; Spleen; Tuberculosis	2001
Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002, Volume: 6, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Creatinine; Female; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant	2002
[Effect of amikacin on experimental tuberculosis of mice (author's transl)]. Kekkaku : [Tuberculosis], 1979, Volume: 54, Issue:1 Topics: Amikacin; Animals; Kanamycin; Male; Mice; Mycobacterium tuberculosis; Tuberculosis	1979
[Experimental studies on the anti-tuberculous effect of BB-K8 (author's transl)]. Kekkaku : [Tuberculosis], 1975, Volume: 50, Issue:8 Topics: Amikacin; Animals; Kanamycin; Male; Mice; Mycobacterium tuberculosis; Tuberculosis	1975
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11 Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis	1992
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:6 Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis	1992
In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9 Topics: Amikacin; Animals; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifabutin; Rifamycins; Tuberculosis	1988
[New active drugs against the tuberculosis bacillus and other mycobacteria]. Medicina, 1986, Volume: 46, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Humans; Lactams; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nalidixic Acid; Nontuberculous Mycobacteria; Rifampin; Tuberculosis	1986
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9 Topics: Amikacin; Animals; Drug Carriers; Injections, Intramuscular; Injections, Intravenous; Kidney; Liposomes; Liver; Lung; Lymph Nodes; Male; Mice; Mice, Inbred C57BL; Spleen; Tuberculosis	1988
Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome. Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Amikacin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Rifampin; Tuberculosis	1986